ArticleCureus2025
Effect of Ultrasound-Guided Subacromial Bursa Injections With Various Doses of Corticosteroid in Subacromial Bursitis: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Subacromial bursitis: current evidence and future directions in injection-based therapies-A narrative review.Annals of medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubacromial bursitis is a common cause of shoulder pain and functional limitation, due to inflammation of the subacromial bursa. Corticosteroid injections are widely used in cases unresponsive to conservative treatments. However, the optimal dose for achieving sustained symptom relief with minimal adverse effects, especially when administered under ultrasound guidance, remains a topic of clinical interest. This study evaluates the efficacy of different corticosteroid doses delivered via ultrasound-guided subacromial bursa injection. METHODOLOGY: This retrospective study was conducted at a tertiary care center between May 2018 and June 2023. Patients aged 30-60 years with MRI-confirmed subacromial bursitis who failed conservative treatment for at least three months were included. Subjects were divided into two groups: a low-dose group receiving 10 mg triamcinolone with 1% lignocaine and a high-dose group receiving 20 mg triamcinolone with 1% lignocaine. Injections were administered under ultrasound guidance using a linear probe. Pain was assessed using the Numerical Rating Scale (NRS) at baseline, and at one week, one month, three months, and six months post-intervention. Data were analyzed using t-tests and chi-square tests.
resultsBoth groups showed significant reductions in pain scores at all post-injection time points (
conclusionsUltrasound-guided corticosteroid injections represent a safe and effective treatment for subacromial bursitis, with higher doses of triamcinolone offering longer-lasting pain relief. The technique improves precision and minimizes risk, making it a valuable tool in managing refractory shoulder pain. Further prospective studies are recommended to validate these findings and develop standardized dosing protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.